An in-depth look to NAVCO PHARMACEUTICALS INC operating, investing, and financing activities

NAV free cash flow for Q3 24 is -25.28 k CAD. For 2023, NAV free cash flow was -1.78 M CAD and operating cash flow was -1.78 M CAD.